26-Nov-2019: The global cell lysis
& disruption market size is expected to reach USD
5.65 billion by 2025 registering a CAGR of 8.31%, according to a new report by
Grand View Research, Inc. Demand for cell lysis & disruption is driven by
the immense growth of the biotechnology sector globally. This is majorly due to
the high adoption of biotech processes in the pharmaceutical, agricultural, and
bio-services industries.
Technological
developments in procedures involved to release cellular organelles have paved
the way for higher adoption of cell disruption methods. As retrieval and
purification of biopharmaceuticals involve cell disruption, a rise in demand
for biopharma would lead to the subsequent growth of the market. In addition,
advancements in the field of proteomics, metabolomics, and personalized
medicine are expected to fuel progressive changes in this sector. However, the
high cost of equipment coupled with the dearth of skilled professionals is
expected to restrain revenue generation to a certain extent.
The restraint can be addressed as the government organizations are releasing substantial funds to fuel development in the biotechnology sector. Merck KGaA; Thermo Fisher Scientific, Inc.; Qiagen NV; F. Hoffmann-La Roche Ltd; Becton Dickinson & Company (BD); Bio-Rad Laboratories, Inc.; Danaher Corporation; Claremont BioSolutions, LLC; and Miltenyi Biotec GmbH are the prominent companies in this market. These companies have undertaken strategies, such as new product development and strategic alliances, to maintain their market share.
The restraint can be addressed as the government organizations are releasing substantial funds to fuel development in the biotechnology sector. Merck KGaA; Thermo Fisher Scientific, Inc.; Qiagen NV; F. Hoffmann-La Roche Ltd; Becton Dickinson & Company (BD); Bio-Rad Laboratories, Inc.; Danaher Corporation; Claremont BioSolutions, LLC; and Miltenyi Biotec GmbH are the prominent companies in this market. These companies have undertaken strategies, such as new product development and strategic alliances, to maintain their market share.
In
depth research report on Cell Lysis & Disruption Market
Further key findings from the study suggest:
·
A rise in development of biologics has subsequently led to a
high demand for better bioprocess solutions
·
The advantages offered by reagent-based methods for isolation
of biological products is attributive to the largest share of the segment in
2018
·
The advantages include an unaltered biological activity of
the sample of interest and ideal compatibility with the laboratory reagents
·
Enzymatic lysis, owing to higher biological specificity, is
anticipated to be the fastest-growing segment over the forecast period
·
Sonication instruments are expected to witness the maximum
CAGR from 2019 to 2025 due to higher adoption rate of these products due to
their reliability
·
Mammalian cell culture systems have grabbed substantial
attention among the biopharmaceutical manufacturers, thus leading to higher
demand for cell lysis protocols for the same
·
Academic research accounted for the largest share in 2018 as
a result of higher usage of cell separation associated protocols in research
facilities
·
Substantial research in the development of the nucleic
acid-derived products is expected to drive progress in this application in the
coming years
·
APAC is projected to be the fastest-growing regional cell
lysis & disruption market due to lucrative opportunities offered by
emerging nations, which has attracted investments from global firms
Grand View Research
has segmented the global cell lysis & disruption market on the basis of
technique, product, cell type, application, end use, and region:
Cell Lysis & Disruption Technique Outlook (Revenue, USD
Million, 2014 - 2025)
·
Reagent-based
·
Detergent
·
Enzymatic
·
Physical Disruption
·
Mechanical Homogenization
·
Ultrasonic Homogenization
·
Pressure Homogenization
·
Temperature Treatments
Cell Lysis & Disruption Product Outlook (Revenue, USD
Million, 2014 - 2025)
·
Instruments
·
High Pressure Homogenizers
·
Sonicator
·
French Press
·
Microfluidizer
·
Bead Mill
·
Other Instruments
·
Reagents & Consumables
·
Enzymes
·
Detergent Solutions
·
Ionic Detergent
·
Nonionic Detergent
·
Zwitterionic Detergent
·
Kits & Reagents
Cell Lysis & Disruption Cell Type Outlook (Revenue, USD
Million, 2014 - 2025)
·
Mammalian Cells
·
Bacterial Cells
·
Yeast/Algae/Fungi
·
Plant Cells
Cell Lysis & Disruption Application Outlook (Revenue, USD
Million, 2014 - 2025)
·
Protein Isolation
·
Downstream Processing
·
Cell Organelle Isolation
·
Nucleic Acid Isolation
Cell Lysis & Disruption End Use Outlook (Revenue, USD
Million, 2014 - 2025)
·
Academic & Research Institutes
·
Hospitals & Diagnostic Labs
·
Cell Banks
·
Pharmaceutical & Biotechnology Companies
Browse
more research reports of this category:
About
Grand View Research
Grand View Research, Inc. is the
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
No comments:
Post a Comment